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Dear Editor, Use of only antibody-based assays may delay or miss the diagnosis in individuals with recent HIV acquisition who are capable of transmitting HIV to others. By the use of improved diagnostic approaches like fourth-generation enzyme-linked immunosorbent assay (ELISA), HIV RNA PCR, these individuals can be diagnosed in a timely manner.
1,2 Although nucleic acid testing is highly sensitive and specific, it is highly time consuming, laborious, and expensive. 3 The current study was undertaken to assess the capability of fourth-generation ELISA to reduce the diagnostic window period in primary HIV infection.
The study was conducted from April to October 2009. Eighty seven participants were recruited, which included spouses of HIV-sero-positive patients (77) and sexually transmitted disease (STD) clinic attendees with multiple sexual partners (10). Participants were tested for HIV using 3 different rapid antibody tests and second and third-generation ELISA. Sera that were negative by both rapid tests and ELISA were tested by fourth-generation ELISA (Genscreen plus Ag-Ab test: Bio-Rad Laboratories, Hercules, California). Samples positive by fourth-generation ELISA were confirmed by reverse transcription polymerase chain reaction (RT-PCR) using AMPLICOR HIV-1 Monitor test, version 1.5, following the standard procedure.
Out of the 77 spouses, 12 were negative by the rapid tests and ELISA (both second and third generation). One out of these 12 sera was positive by fourth-generation ELISA. However, this patient exhibited a viral load of <400 copies/mL. Repeat RT-PCR was performed after 1 week, which exhibited a viral load of 1000 copies/mL. Out of the 10 STD clinic attendees, 7 were negative for HIV by rapid tests and ELISA (both second and third generation). Among these samples, on testing by fourth-generation ELISA, only 1 was found to be positive. This patient showed a viral load of 1726 copies/mL (Table 1) .
In our study, rapid tests and ELISA (both second and third generation) failed to detect 2 of the total 87 samples tested.
In one study 4 from India, the performance of fourth-generation ELISA was evaluated and it found discordant results in 0.03% cases compared to 2.2% in our study. On the contrary, another study 5 gave conflicting results in which a suspected HIV-positive case was tested with a fourth-generation HIV screening test and was found to be negative but 7 days later, a second blood sample was tested for HIV antibodies and was found to be positive.
The results of our pilot study indicate that fourth-generation ELISA may be able to detect a small number of persons, who may be in the window period of HIV infection; however, larger studies are required to validate this observation. 
